In vivo Angiotensin II AT1 receptor blockade selectively inhibits LPS-induced innate immune response and ACTH release in rat pituitary gland.
about
Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.Angiotensin II AT1 receptor blockade ameliorates brain inflammation.Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytesAngiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders.Angiotensin II AT1 receptor blocker candesartan prevents the fast up-regulation of cerebrocortical benzodiazepine-1 receptors induced by acute inflammatory and restraint stress.Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.Six commercially available angiotensin II AT1 receptor antibodies are non-specific.Candesartan ameliorates impaired fear extinction induced by innate immune activation.The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonismEndocrine-Autonomic Linkages.Differential effects of glucocorticoids in the establishment and maintenance of endotoxin tolerance.Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice.Dehydroepiandrosterone and metyrapone partially restore the adaptive humoral and cellular immune response in endotoxin immunosuppressed mice.The effects of angiotensin peptides and angiotensin receptor antagonists on the cell growth and angiogenic activity of GH3 lactosomatotroph cells in vitro.Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages.
P2860
Q34390088-00B855D8-FCD1-4810-9BEF-A7986DAE70FFQ34662044-CBB84406-A02F-4D06-B5D6-FD1D20D6B362Q35612987-BB598441-70F6-42E5-ABE6-802FE9DBD646Q35827935-B903EC10-30C5-4F6F-90C7-E3A9F413D6C4Q36025710-CD4E9705-2B49-4FE2-8F76-A1ABA9DA2CFDQ36410269-7BF4A44B-D78D-45A1-907C-83BB31622F8AQ36429006-D5ABF2BC-BA83-4C24-A95A-02B6534A7322Q36471452-E5FC6740-76BD-4F83-97DB-791E12EFA7FFQ37467929-E15B0413-D7F9-40E1-B7E0-6F12B3849004Q38542455-76939E07-528F-47F6-8512-AE654E3A26A1Q39929445-FB1B37FC-F5EC-4340-88D0-EFD857AE0C99Q42851616-3B8824CF-E00F-48DD-8AED-094740671B8DQ46096702-6D46CE89-F9F5-48A7-93D1-E3A970F59D48Q48601476-23E3DD96-733E-4558-AB23-80601A74A81FQ54573248-48323F02-A757-4000-A586-BBB5005FE511
P2860
In vivo Angiotensin II AT1 receptor blockade selectively inhibits LPS-induced innate immune response and ACTH release in rat pituitary gland.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo Angiotensin II AT1 rec ...... elease in rat pituitary gland.
@en
In vivo Angiotensin II AT1 rec ...... elease in rat pituitary gland.
@nl
type
label
In vivo Angiotensin II AT1 rec ...... elease in rat pituitary gland.
@en
In vivo Angiotensin II AT1 rec ...... elease in rat pituitary gland.
@nl
prefLabel
In vivo Angiotensin II AT1 rec ...... elease in rat pituitary gland.
@en
In vivo Angiotensin II AT1 rec ...... elease in rat pituitary gland.
@nl
P2093
P2860
P1476
In vivo Angiotensin II AT1 rec ...... elease in rat pituitary gland.
@en
P2093
Enrique Sánchez-Lemus
Jaroslav Pavel
Juan M Saavedra
Julius Benicky
P2860
P304
P356
10.1016/J.BBI.2009.04.012
P577
2009-05-07T00:00:00Z